• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[关于头颈部恶性肿瘤化疗的批判性评论]

[Critical remarks on chemotherapy of malignant tumors of the head and neck].

作者信息

Ganzer U, Bier H, Bachert C

出版信息

Laryngol Rhinol Otol (Stuttg). 1987 Apr;66(4):200-4.

PMID:2439860
Abstract

Chemotherapy of head and neck carcinomas has been the subject of 111 relevant publications reporting on more than 4,500 patients in the international literature of the past five years. Results of similar treatment protocols have been grouped together and tumour remission and survival time determined. Chemotherapy did not result in cure or increased survival times, neither alone nor in combination with irradiation nor when applied as adjuvant treatment. Inductive chemotherapy may result in producing a favourable effect on the prognosis of advanced carcinomas. The beneficial character of palliative chemotherapy is a generally accepted fact. Improvement of treatment results will be achieved only via centrally coordinated, randomised and prospective studies as well as by intensive fundamental research.

摘要

头颈部癌的化疗一直是过去五年国际文献中111篇相关出版物的主题,这些出版物报道了4500多名患者。已将类似治疗方案的结果进行汇总,并确定了肿瘤缓解情况和生存时间。化疗无论是单独使用、与放疗联合使用还是作为辅助治疗,均未导致治愈或延长生存时间。诱导化疗可能会对晚期癌症的预后产生有利影响。姑息化疗的有益特性是一个普遍公认的事实。只有通过集中协调、随机和前瞻性研究以及深入的基础研究,才能实现治疗效果的改善。

相似文献

1
[Critical remarks on chemotherapy of malignant tumors of the head and neck].[关于头颈部恶性肿瘤化疗的批判性评论]
Laryngol Rhinol Otol (Stuttg). 1987 Apr;66(4):200-4.
2
[Chemotherapy of head and neck cancer].[头颈部癌症的化疗]
Gan To Kagaku Ryoho. 1996 Feb;23(3):277-82.
3
[Chemotherapy of advanced head and neck tumors. A prospective randomized study comparing the effectiveness of chemotherapy alone to a chemo-radiotherapy procedure].[晚期头颈肿瘤的化疗。一项前瞻性随机研究,比较单纯化疗与化疗-放疗联合治疗的有效性]
Laryngol Rhinol Otol (Stuttg). 1987 Apr;66(4):205-10.
4
Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck.局部晚期头颈部鳞状细胞癌的术前序贯化疗
Head Neck. 2005 Apr;27(4):311-9. doi: 10.1002/hed.20155.
5
[Palliative antineoplastic chemotherapy of patients with head and neck tumors].[头颈部肿瘤患者的姑息性抗肿瘤化疗]
HNO. 1994 May;42(5):275-9.
6
[Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].头颈部鳞状细胞癌的多药化疗与放疗治疗
Gan To Kagaku Ryoho. 1989 Sep;16(9):3111-8.
7
Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.顺铂、甲氨蝶呤、博来霉素和长春新碱(CABO)新辅助化疗用于治疗Ⅲ期和Ⅳ期头颈部鳞状细胞癌患者。
Eur J Surg Oncol. 1989 Dec;15(6):568-74.
8
Pretreatment with chemotherapy in patients with advanced head and neck cancer.晚期头颈癌患者的化疗预处理。
J Otolaryngol. 1985 Dec;14(6):391-3.
9
[Results of primary chemotherapy in 44 patients with advanced squamous cell carcinoma in the area of the head and neck].[44例晚期头颈部鳞状细胞癌患者的初始化疗结果]
HNO. 1984 Nov;32(11):454-9.
10
c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.c-erbB-2癌蛋白在头颈部血管生成不良的鳞状细胞癌中过度表达,但与细胞毒性治疗反应或生存率无关。
Anticancer Res. 2000 Mar-Apr;20(2A):997-1004.

引用本文的文献

1
Systemic therapy strategies for head-neck carcinomas: Current status.头颈部癌的全身治疗策略:现状
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2012;11:Doc03. doi: 10.3205/cto000085. Epub 2012 Dec 20.
2
Chemotherapeutic drug resistance in the management of head and neck cancer.头颈部癌治疗中的化疗耐药性。
Eur Arch Otorhinolaryngol. 1993;250(4):200-8. doi: 10.1007/BF00171524.
3
Glutathione content and gamma-glutamyltranspeptidase activity in squamous cell head and neck cancer xenografts.头颈部鳞状细胞癌异种移植瘤中的谷胱甘肽含量及γ-谷氨酰转肽酶活性
Arch Otorhinolaryngol. 1988;245(3):166-9. doi: 10.1007/BF00464020.